Wouter Rozemeijer

689 total citations
14 papers, 167 citations indexed

About

Wouter Rozemeijer is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Wouter Rozemeijer has authored 14 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Wouter Rozemeijer's work include Infective Endocarditis Diagnosis and Management (5 papers), Streptococcal Infections and Treatments (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Wouter Rozemeijer is often cited by papers focused on Infective Endocarditis Diagnosis and Management (5 papers), Streptococcal Infections and Treatments (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Wouter Rozemeijer collaborates with scholars based in Netherlands and United States. Wouter Rozemeijer's co-authors include Robin Soetekouw, Bjorn L. Herpers, Marc J. M. Bonten, G. van Twillert, Jan T. M. van der Meer, Jan M. Prins, Thomas W. van der Vaart, Rogier R. Jansen, Jan A. Veenstra and Paul H. M. Savelkoul and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Medical Journal of Australia.

In The Last Decade

Wouter Rozemeijer

14 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wouter Rozemeijer Netherlands	7	90	78	37	34	32	14	167
Maria Rita Elmor de Araújo Brazil	8	39 0.4×	64 0.8×	25 0.7×	25 0.7×	36 1.1×	17	179
Guillermo Ezpeleta Spain	10	155 1.7×	130 1.7×	44 1.2×	25 0.7×	36 1.1×	18	245
Jose Ferrolino United States	8	111 1.2×	73 0.9×	47 1.3×	14 0.4×	30 0.9×	22	222
Lawrence Eisenstein United States	8	79 0.9×	90 1.2×	11 0.3×	29 0.9×	47 1.5×	12	191
Ricardo Fernández Roblas Spain	8	125 1.4×	171 2.2×	24 0.6×	59 1.7×	39 1.2×	14	256
Ana Gil-Brusola Spain	8	119 1.3×	185 2.4×	26 0.7×	24 0.7×	15 0.5×	16	258
William F. Pomputius United States	7	95 1.1×	90 1.2×	41 1.1×	10 0.3×	10 0.3×	14	242
Elif Şahin Horasan Türkiye	8	70 0.8×	68 0.9×	22 0.6×	9 0.3×	22 0.7×	17	203
Irene Muñoz‐Gallego Spain	10	151 1.7×	83 1.1×	63 1.7×	19 0.6×	37 1.2×	18	231
Ai Ling Tan Singapore	10	182 2.0×	169 2.2×	24 0.6×	16 0.5×	18 0.6×	37	282

Countries citing papers authored by Wouter Rozemeijer

Since Specialization

Citations

This map shows the geographic impact of Wouter Rozemeijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Rozemeijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Rozemeijer more than expected).

Fields of papers citing papers by Wouter Rozemeijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Rozemeijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Rozemeijer. The network helps show where Wouter Rozemeijer may publish in the future.

Co-authorship network of co-authors of Wouter Rozemeijer

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Rozemeijer. A scholar is included among the top collaborators of Wouter Rozemeijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Rozemeijer. Wouter Rozemeijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pattacini, Laura, Wouter Rozemeijer, Barbara M.A. Schout, et al.. (2024). “Catheter replacement in catheter-associated urinary tract infection: current state of evidence “. European Journal of Clinical Microbiology & Infectious Diseases. 43(8). 1631–1637. 1 indexed citations

Vaart, Thomas W. van der, Jan M. Prins, Cornelis H. van Werkhoven, et al.. (2023). Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias. Clinical Infectious Diseases. 77(1). 9–15. 13 indexed citations

Rozemeijer, Wouter, et al.. (2022). Bacterial DNA load in Staphylococcus aureus bacteremia is significantly higher in intravascular infections. PLoS ONE. 17(4). e0266869–e0266869. 5 indexed citations

Altenburg, Josje, Inez Bronsveld, Martijn D. de Kruif, et al.. (2022). Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Respiratory Research. 23(1). 330–330. 11 indexed citations

Altenburg, Josje, et al.. (2022). The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol. Contemporary Clinical Trials Communications. 30. 101045–101045. 3 indexed citations

Vaart, Thomas W. van der, Jan M. Prins, Robin Soetekouw, et al.. (2022). All-Cause and Infection-Related Mortality in Staphylococcus aureus Bacteremia, a Multicenter Prospective Cohort Study. Open Forum Infectious Diseases. 9(12). ofac653–ofac653. 29 indexed citations

Vaart, Thomas W. van der, Jan M. Prins, Robin Soetekouw, et al.. (2021). Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia. Clinical Infectious Diseases. 74(8). 1442–1449. 34 indexed citations

Jansen, Slinger, et al.. (2018). Feasibility of a quantitative polymerase chain reaction assay for diagnosing pneumococcal pneumonia using oropharyngeal swabs. Molecular Biology Reports. 46(1). 1013–1021. 2 indexed citations

Rozemeijer, Wouter, et al.. (2016). A patient with sarcoidosis and a cryptococcal infection of the skull. The Medical Journal of Australia. 204(9). 353–353. 2 indexed citations

10.

Rozemeijer, Wouter, Pamela S. Fink, Eduardo A. Peña Rojas, et al.. (2015). Evaluation of Approaches to Monitor Staphylococcus aureus Virulence Factor Expression during Human Disease. PLoS ONE. 10(2). e0116945–e0116945. 42 indexed citations

11.

Rozemeijer, Wouter, et al.. (2014). A life-threatening complication of an ordinary urinary tract infection?. PubMed. 72(9). 502, 505–502, 505. 2 indexed citations

12.

Rozemeijer, Wouter, et al.. (2012). [Streptococcus suis meningitis in a meat factory employee].. PubMed. 156(44). A5080–A5080. 3 indexed citations

13.

Rozemeijer, Wouter, Timothy U. Jiya, Martine C. Rijnsburger, et al.. (2011). Abiotrophia defectiva infection of a total hip arthroplasty diagnosed by 16S rRNA gene sequencing. Diagnostic Microbiology and Infectious Disease. 70(1). 142–144. 7 indexed citations

14.

Rozemeijer, Wouter, et al.. (2009). Vibrio cholerae non-O1 non-O139 infection in an immunocompromised patient returning from Spain, July 2009. Eurosurveillance. 14(32). 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact